Dr Bhupendra Prajapati, Professor at Parul University, Achieves i10-index of 151 in Pharmacy Science 2026

An i10-index of 151 is a remarkable figure. It means that at least 151 separate papers by Dr Bhupendra Gopalbhai Prajapati have each been cited ten or more times, a breadth of influential output that few researchers reach. He is a Professor in the Research Cadre of Parul University's Faculty of Pharmacy, with an h-index of 34, and he appears in the Stanford-Elsevier global rankings of the top two percent of scientists.

Where some researchers are known for a small number of heavily cited papers, an i10-index of 151 describes something different: a large body of work, sustained over time, a great deal of which the research community has drawn upon.

What the Metrics Describe

The i10-index counts papers with at least ten citations each. A figure of 151 indicates both productivity and consistent relevance, since each of those papers had to be useful enough to be cited ten times by other researchers. Combined with an h-index of 34, the profile is that of a prolific and widely used researcher in the pharmaceutical sciences.

The Field: Pharmacology and Drug Delivery

Dr Prajapati's fields, as recorded, are pharmacology and pharmacy, with work spanning oncology and carcinogenesis. Drug delivery, a central concern of modern pharmaceutical research, addresses not the discovery of a drug but the problem of getting it to the right place in the body, at the right concentration, for the right duration. It is the difference between a compound that works in a laboratory and a medicine that works in a patient.

Research in this area underpins much of contemporary pharmaceutics, from controlled-release formulations to targeted therapies, and it is among the most active fields in Indian pharmaceutical science. A faculty that includes a researcher with a citation record like Dr Prajapati's has genuine depth in it.

Part of a Pharmacy Research Cluster

Dr Prajapati is not an isolated figure. Of the seven Parul University faculty in the Stanford-Elsevier rankings, several sit within the Faculty of Pharmacy, which points to a concentration of research strength rather than a single notable hire. This cluster is examined in the guide to pharmacy at Parul University. The faculty's research is supported by infrastructure recognised by the Department of Scientific and Industrial Research.

For a pharmacy student, that concentration matters more than any single name. It indicates a department where research is a genuine activity across multiple senior faculty, which is what makes postgraduate study and a research career possible from within it.

Why Breadth of Output Matters

There is a meaningful distinction between a researcher known for one landmark paper and one with a large body of consistently cited work. The first can reflect a single fortunate result. The second, which an i10-index of 151 describes, reflects a sustained capacity to produce work the field finds useful, year after year.

For a research student, the second kind of supervisor is often the more valuable, because a productive research programme generates a steady flow of problems for students to work on, rather than a single celebrated line of inquiry that may already be complete. Breadth of output is, in effect, breadth of opportunity.

Also See: Parul University Admission

How to Verify This Yourself

As with any such claim, the figures are public and worth checking directly.

• Search the name: Dr Bhupendra Gopalbhai Prajapati's citation record is available through public citation databases.

• Check the Stanford-Elsevier dataset: The ranking is openly published and searchable by name and institution.

• Match the field interest: An i10-index is impressive, but relevance to a student's intended area matters more, and the publication record shows it.

A prospective student who runs this check for the faculty of any pharmacy programme they are considering will learn more in twenty minutes than a prospectus conveys in twenty pages.

A Note on What the Metrics Do Not Say

Citation metrics measure research influence and nothing else. They do not measure whether a researcher teaches well or supervises attentively, and a prospective student should assess those qualities separately.

What a strong record does establish is that a researcher's work is used and respected by others in the field, which is a fact, independently verifiable, and not a matter of an institution's own account of itself. That is the specific and limited thing these profiles are offered to demonstrate, and it is worth exactly what it is: a reliable signal that the research is real.

Also Read: Parul University Placement

Drug Delivery, Oncology, and Why the Combination Matters

Dr Prajapati's recorded fields include oncology and carcinogenesis alongside pharmacology, and the pairing with drug delivery is significant. Cancer therapeutics are among the clearest cases where delivery is as important as the drug, because many cancer treatments are toxic to healthy tissue and their value depends on reaching the tumour while sparing the rest of the body.

Research that spans both the pharmacology of a disease and the delivery of its treatment sits at a genuinely useful intersection. For a student, it illustrates how the sub-fields of pharmaceutical science connect, and why a faculty with strength across several of them offers a richer education than one strong in a single area.

Disclaimer: This article has been published as part of the marketing activity between Parul University and Careers360.